Michael Reardon, MD, addresses the typical questions asked by patients in regards to TAVR: What is the risk of dying? What are the risks of complications? How quickly will I recover? How long will it last? How well does it work? This presentation was a part of the 2018 Re-Evolution Summit.
Created by
Presenters
Allison Family Distinguished Chair of Cardiovascular Research, Department of Cardiovascular Surgery
Professor of Cardiovascular Surgery, Institute for Academic Medicine
Full Member, Research Institute
Biography Dr. Michael J. Reardon is a native Houstonian who attended Baylor College of Medicine where he graduated with honors and as a member of AOA. He did his general surgery residency under Dr. Michael DeBakey and cardiothoracic residency ...